您的位置: 首页 > 农业专利 > 详情页

REGULATABLE CHIMERIC ANTIGEN RECEPTOR
专利权人:
Novartis AG
发明人:
BROGDON, Jennifer,ENGELS, Boris,GLASS, David Jonathan,GRANDA, Brian,HASTEWELL, John,LOEW, Andreas,MANNICK, Joan,MILONE, Michael,MURPHY, Leon,SELLERS,William Raj,SONG, Huijuan,VASH, Brian Edward,WEILER
申请号:
EP14872734
公开号:
EP3087101A4
申请日:
2014.12.19
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
Compositions and methods relating to regulatable chimeric antigen receptors (RCARs), where the intracellular signaling or proliferation of the RCAR can be controlled to optimize the use of an RCAR-expressing cell to provide an immune response, are provided. For example, a RCAR can comprise a dimerization switch that, upon the presence of a dimerization molecule, can couple an intracellular signaling domain to an extracellular recognition element, e.g., an antigen binding domain, an inhibitory counter ligand binding domain, or costimulatory ECD domain. An RCAR can be engineered to include an appropriate antigen binding domain that is specific to a desired antigen target and used in the treatment of a disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充